Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 40
Healthy volunteers: yes

Brief summary:
The objective of the current study is to investigate the relative bioavailability of two different batches of a 2.5 mg linagliptin / 1000 mg metformin fixed dose combination tablet (FDC).

Detailed description:

Arms:
arm 1: Fixed dose combination tablet arm 2: Fixed dose combination tablet

Interventions: intervention 1: Linagliptin/Metformin (standard batch) intervention 2: Linagliptin/Metformin (side batch)
Intervention descriptions: intervention 1: Fixed dose combination tablet intervention 2: Fixed dose combination tablet

Protocol document: